本月全球药品研发进展取得成效的药物有55个,较上月增加了2个,其中进入注册阶段的药物数量大幅上升,进入注册前阶段和Ⅲ期临床研究阶段的药品数量均有所减少。进入注册阶段的有35个,比上月增加14个。其中6个为全球首次注册的新活性物质、新制剂,其余29个均为在新市场补充注册。本月全球首次注册6个药品,较上月减少2个。其中 There were 55 drugs that made progress in global drug research and development this month, an increase of 2 last month. The number of drugs entering the registration phase increased sharply, and the number of drugs entering the pre-registration phase and the phase III clinical research phase decreased. 35 have entered the registration phase, an increase of 14 from the previous month. Six of them were the first new active substances and new preparations registered in the world, and the remaining 29 were newly registered in the new markets. This month the world’s first registration of six drugs, a decrease of 2 last month. among them